News

Explore the impact of ACA tax credits on enrollment, premiums and healthcare access as Congress debates subsidy extensions for 2026 and beyond.

Yuvezzi is the first combination product that treats adults with presbyopia. It will be available in the second quarter of 2026.

Urgent care spending surges over 50% from 2018 to 2022, driven by increased visits, highlighting its vital role in healthcare access.

Although Medicaid expansion has been linked to lower mortality, significant racial disparities persist.

CMS announced 15 drugs for Medicare price negotiations under the IRA, representing $27 billion in spending and treating conditions such as diabetes, cancer, and autoimmune conditions. Here are three insights on the list from industry experts.

Chris Klomp, the director of Medicare and the deputy administrator at CMS, spoke about the proposed rule designed to curtail at-home risk assessments and other tactics that large insurers have used to game Medicare Advantage risk adjustment.

A new study has identified the brain connectivity patterns that lead to cognitive difficulties in patients with schizophrenia, suggesting potential targets for therapeutic intervention in early psychosis stages.

More Americans are tracking and changing their sleep habits, but the growing cultural focus on sleep data is also increasing anxiety, with orthosomnia leaving many people awake at night.

Proposed Medicare Advantage payment updates spark concern among insurers and investors, raising questions about risk adjustment and potential impacts on beneficiaries.

Lung cancer remains the leading cause of cancer deaths in the U.S. in 2026 and is expected to account for an estimated 229,410 new cases.

Unrest is escalating in Minnesota after federal immigration officers killed two civilians including ICU nurse Alex Pretti, prompting more than 60 Minnesota CEOs and national nursing organizations to call for de-escalation, accountability and a transparent investigation of the incidents.

In a Q&A, Jeffrey Hogan, managing director and co-founder of Judi Group, talks about the importance of identifying hidden costs and contract conflicts of healthcare vendors.

Legislation reforms pharmacy benefit managers by mandating price transparency, eliminating certain compensation models, and providing CMS funding to enforce contract terms.

Medicare's 2024 initiative to address health-related social needs faces challenges, with over 25% of claims denied, highlighting barriers to effective care.

In this interview, Emma Kaplan-Lewis, M.D., clinical quality director for HIV, hepatitis and sexual health services at NYC Health + Hospitals, discusses the results of her latest case study on PrEP uptake and why it’s important to “celebrate success.”

In this interview, Danielly Fausto, Ph.D., physical education researcher at the Santa Catarina State University in Brazil, discusses the importance of midlife physical activity, how she’s come to terms with the initially "disappointing" results of her recent study and why it’s essential to keep talking about menopause.

Lawmakers from both parties grill insurance companies over claims denials, prior authorization delays, and vertical integration.

Physician groups prioritize patient care leadership and Medicaid reforms for 2026, addressing workforce challenges and public health issues in upcoming legislation.

The trade associations salvos came the day before the CEOs of five major insurers are expected to face tough questioning at two congressional hearings.

Sleep deprivation of 21 hours or more significantly reduces cooperation and overall team performance, causing individuals to prioritize personal success over collective effectiveness while overestimating how well their team is functioning.

Judi Group brings together top benefits specialists, ERISA attorneys, actuarial analysts, and technologists to assess risk and protect fiduciary integrity across vendors and solutions.

A survey finds that many dermatology patients struggle to understand skin cancer jargon, raising concerns about communication gaps during clinical visits.

Gedatolisib is an investigational treatment for patients with HR+/HER2- PIK3CA wild-type advanced breast cancer

Research reveals oral probiotics and synbiotics improve atopic dermatitis symptoms, while studies on other skin conditions remain limited.

Dynavax's Z-1018 shingles vaccine in a phase 1/2 trial showed comparable effectiveness to Shingrix with fewer injection site reactions in adults aged 50 to 69.

Self-administered HPV screening promises greater patient comfort and higher detection rates, though solutions for large-scale rollout and follow-up are still needed.

In a conversation with Abby Kim, Pharm.D., of Prime Therapeutics, she shared that oncology pharmacists bridge critical gaps in precision medicine, enhancing patient care by streamlining biomarker testing and ensuring timely access to effective treatments.